| CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
| 1092563-25-1 | 4-[4-(4,4,5,5-四甲基[1,3,2]二氧杂硼杂环戊烷-2-基)苄基]硫代吗啉1,1-二氧化物 | 4-[4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzyl]thiomorpholine 1,1-dioxide | C17H26BNO4S | 351.27 | | |
| 1092563-29-5 | 4-[2-氟-4-(4,4,5,5-四甲基[1,3,2]二氧杂硼杂环戊烷-2-基)苄基]硫代吗啉1,1-二氧化物 | 4-[2-fluoro-4-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzyl]thiomorpholine 1,1-dioxide | | | | |
| 1092563-41-1 | 3-甲基-4-(吡咯烷-1-基甲酰基)苯硼酸频哪醇酯 | (2-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)(pyrrolidin-1-yl)methanone | C18H26BNO3 | 315.21494 | | |
| 1092563-48-8 | | 3-chloro-4-(morpholinocarbonyl)phenylboronic acid, pinacol ester | C17H23BClNO4 | 351.63 | | |
| 1092563-66-0 | 1-(4-(4-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)-1h-吡唑-1-基)哌啶-1-基)乙烷-1-酮 | 1-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyr | C16H26BN3O3 | 319.21 | | |
| 1092563-67-1 | tert-butyl 4-[5-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]piperidine-1-carboxylate | | C20H34BN3O4 | 391.3113 | | |
| 1092563-68-2 | 1-(1-boc-4-哌啶基)-3-甲基吡唑-4-硼酸频哪醇酯 | 1-(1-boc-4-piperidyl)-3-methylpyrazole-4-boronic acid pinacol ester | C20H34BN3O4 | 391.32 | | 503.3±50.0 °C(Predicted) |
| 1092563-71-7 | 3-{[4-(四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-1h-吡唑-1-基]甲基}哌啶-1-羧酸叔丁酯 | tert-butyl 3-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrazol-1-yl]methyl}piperidine-1-carboxylate | | | | |
| 1092563-72-8 | 4-{[4-(四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-1h-吡唑-1-基]甲基}哌啶-1-羧酸叔丁酯 | tert-butyl 4-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrazol-1-yl]methyl}piperidine-1-carboxylate | C20H34BN3O4 | 391.32 | | 500.4±20.0 °C(Predicted) |
| 1092563-74-0 | 3-[4-(四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)-1h-吡唑-1-基]哌啶-1-羧酸叔丁酯 | tert-butyl 3-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1h-pyrazol-1-yl]piperidine-1-carboxylate | C19H32BN3O4 | 377.28608 | | |
| 1092563-81-9 | 8-BROMO-3,4-DIHYDRONAPHTHALEN-2(2H)-ONE | 8-bromo-3,4-dihydronaphthalen-2(1H)-one | C8H7BrN2O | 227.06 | | |
| 1092563-82-0 | | 8-bromoquinoxalin-2(1h)-one | | | | |
| 1092564-34-5 | 3-(三氟甲基)-4-(吗啉-4-基甲酰基)苯基硼酸频哪醇酯 | morpholino(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)phenyl)methanone | C18H23BF3NO4 | 385.186 | | |
| 1092564-35-6 | 3-甲氧基-4-(吗啉-4-基甲酰基)苯硼酸频哪醇酯 | 4-[2-Methoxy-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]carbonylmorpholine | C18H26BNO5 | 347.22 | | |
| 1092566-65-8 | 3-(5-甲基-1,2,4-噁二唑-3-基)苯甲酸甲酯 | methyl 3-(5-methyl-1,2,4-oxadiazol-3-yl)benzoate | C11H10N2O3 | 218.211 | | |
| 1092568-84-7 | 3-氨基甲酰亚胺基苯甲酸甲酯乙酸酯 | methyl 3-carbamimidoylbenzoate acetate | C11H14N2O4 | 238.24 | | |
| 1092568-85-8 | 3-[5-(((二甲氨基)亚甲基)氨基)嘧啶-2-基]苯甲酸甲酯 | 3-[5-(((Dimethylamino)methylene)amino)pyrimidin-2-yl]benzoic acid methyl ester | C15H16N4O2 | 284.31 | | |
| 1092568-86-9 | 3-(5-羟基嘧啶-2-基)苯甲酸 | 3-(5-hydroxypyrimidin-2-yl)benzoic acid | C11H8N2O3 | 216.19 | | |
| 1092568-87-0 | 3-(5-羟基嘧啶-2-基)苯甲酸甲酯 | 3-(5-hydroxypyrimidin-2-yl)benzoic acid methyl ester | C12H10N2O3 | 230.22 | | |
| 1092574-91-8 | | 3-cyclohexyl-4-fluoro-1h-indole | | | | |
| 1092578-43-2 | 托伐替尼杂质20 | tofacitinib impurity 20 | | | | |
| 1092578-46-5 | | (3R,4S)-tofacitinib | C16H20N6O | 312.37 | | |
| 1092578-47-6 | | (3S,4S)-tofacitinib | C16H20N6O | 312.37 | | |
| 1092578-48-7 | | (3S,4R)-tofacitinib | C16H20N6O | 312.37 | | |
| 1092578-51-2 | 3,7-双[4-(9h-咔唑-9-基)苯基]-2,6-二苯基苯并[1,2-b:4,5-b']二呋喃 | czbdf | C58H36N2O2 | 792.9400000000001 | | |
| 1092579-75-3 | 5-溴-4-氯-3-碘-1h-吡咯并[2,3-b]吡啶 | 5-bromo-4-chloro-3-iodo-1h-pyrrolo[2,3-b]pyridine | C7H3BrClIN2 | 357.37 | | |
| 1092579-76-4 | 5-溴-3-碘-4-甲氧基-1H-吡咯并[2,3-b]吡啶 | 5-Bromo-3-iodo-4-methoxy-1H-pyrrolo[2,3-b]pyridine | C8H6BrIN2O | 352.95 | | |
| 1092579-78-6 | 5-溴-4-氯-3-碘-1h-吡唑并[3,4-b]吡啶 | 5-bromo-4-chloro-3-iodo-1h-pyrazolo[3,4-b]pyridine | C6H2BrClIN3 | 358.36 | | 426.2±40.0°C at 760 mmHg |
| 1092579-95-7 | 5-溴-4-甲氧基-1h-吡咯并[2,3-b]吡啶 | 5-bromo-4-methoxy-1h-pyrrolo[2,3-b]pyridine | C8H7BrN2O | 227.06 | | |
| 1092579-96-8 | 4-三氟甲基-7-氮杂吲哚 | 4-(trifluoroMethyl)-1H-pyrrolo[2,3-b]pyridine | C8H5F3N2 | 186.13 | | |
| 1092579-98-0 | 5-溴-4-(三氟甲基)-1h-吡咯并[2,3-b]吡啶 | 5-bromo-4-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridine | C8H4BrF3N2 | 265.03 | | |
| 109258-19-7 | | (3,6-pyridazinediylbis(oxyethylene))bis(trimethyl-ammoniu diiodide | | | | |
| 109258-22-2 | | n-(1,1,3-trimethylbutyl)-1-piperidineacetamid hydrochloride | | | | |
| 109258-48-2 | | n-(1,1-dimethylhexyl)-4-morpholineacetamid hydrochloride | | | | |
| 109258-59-5 | | benzoic acid (4-hydroxyimino-3-methyl-cyclohexa-2,5-dienylidene)-hydrazide | | | | |
| 109258-71-1 | | aminolevulinic acid related compound b | C14H13NO5 | 275.26 | 90-93 °C | 428.1±25.0 °C(Predicted) |
| 1092580-04-5 | 5-bromo-4-iodo-1H-pyrrolo[2,3-b]pyridine | | C7H4N2BrI | 322.9279 | | |
| 1092582-89-2 | (3aR,3a'R,8aS,8a'S)-2,2'-(戊烷-3,3-二基)双(8,8a-二氢-3aH-茚并[1,2-d]恶唑) | (3AR,3a'R,8aS,8a'S)-2,2'-(pentane-3,3-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole) | C25H26N2O2 | 386.4862 | | |
| 109262-45-5 | | bis-(2-diisopropyloxyphosphinyl-ethyl)-sulfide | C16H36O6P2S | 418.47 | | |
| 109265-99-8 | | n-(4-(((imino((imino((5-(4-nitrophenyl)-1,3,4-thiadiazol-2-yl)amino)methyl )amino) methyl)amino)sulfonyl)phenyl)-acetamid monohydrochloride | | | | |
| 1092657-05-0 | 5-(3-甲氧基-4-氟苯基)-2h-四唑 | 5-(4-fluoro-3-methoxyphenyl)-2h-tetrazole | | | | |
| 109266-84-4 | | 4-((2-methyl-6-nitro-2h-1,4-benzoxazin-3-yl)amino)-benzeneacetic aci methyl | | | | |
| 1092679-51-0 | way-100635马来酸盐 | way-100635 maleate | C25H34N4O2.C4H4O4 | 538.64 | | |
| 1092683-48-1 | | 1-[(3-nitro-1h-pyrazol-5-yl)carbonyl]piperidine | | | | |
| 1092683-57-2 | 4-溴-1h-吡唑-5-羧酸 | 4-bromo-1h-pyrazole-5-carboxylic acid | C4H3BrN2O2 | 190.98 | | |
| 1092689-33-2 | (4-(1,2,4,5-四嗪-3-基)苯基)甲胺 | (4-(1,2,4,5-tetrazin-3-yl)phenyl)methanamine | | | | |
| 109269-35-4 | | 3-pyridinecarboxamide, 1,4-dihydro-5-bromo-n-(2,6-diethylphenyl)-1,6-dimethyl-4 | | | | |
| 1092693-68-9 | 2,2-二氟-3-羟基戊酸乙酯 | ethyl 2,2-difluoro-3-hydroxypentanoate | | | | |
| 1092693-73-6 | 2,2-二氟-3-[(2-甲基-1-氧代-2-丙烯-1-基)氧基]戊酸叔丁酯 | tert-butyl 2,2-difluoro-3-(methacryloyloxy)pentanoate | C13H20F2O4 | 278.29 | | |
| 1092695-12-9 | | n-(dichlorophosphino)dibenzo[b,f]azepine | | | | |
m.cnreagent.com